Skip to main content
. 2021 May 18;2021(5):CD007579. doi: 10.1002/14651858.CD007579.pub3

Lee 2002.

Study characteristics
Methods RCT
Participants Inclusion criteria:
  • Women undergoing elective CS under spinal anaesthesia.

  • N = 60 women randomised


Exclusion criteria:
Interventions Intervention 1: 5HT3 antagonist (Comparison 1)
  • Granisetron 10 ug/kg

  • N = 15


Intervention 2: 5HT3 antagonist (Comparison 1)
  • Granisetron 20 ug/kg

  • N = 15


Intervention 3: 5HT3 antagonist (Comparison 1)
  • Granisetron 30 ug/kg

  • N = 15


Comparator: placebo
  • N = 15

Outcomes VAS pain scores, emetic episodes, emesis scores, side effects
Notes Setting: Samsung Cheil Hospital, Seoul, South Korea.
Dates: not reported.
Funding source: not reported.
Declaration of interest: not reported.
Full paper in English.
There were no data for this review
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Quote: "randomised according to computerised list"
Allocation concealment (selection bias) Unclear risk Unrelated anaesthetist prepared syringes
Blinding of participants and personnel (performance bias)
All outcomes Unclear risk As above
Blinding of outcome assessment (detection bias)
All outcomes Low risk Quote: "post operative emetic scores were recorded by anesthesiologist blinded to which antiemetic each patient had received"
Incomplete outcome data (attrition bias)
All outcomes Unclear risk Not clear if any data incomplete/missing
Selective reporting (reporting bias) Unclear risk outcomes appear to be consistent with methods, but we did not assess the trial protocol
Other bias Unclear risk Nil apparent